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FBN2a b s t r a c t
Congenital contractural arachnodactyly (CCA, OMIM: 121050) is an autosomal dominant condition
that shares skeletal features with Marfan syndrome (MFS, OMIM: 154700), including contractures,
arachnodactyly, dolichostenomelia, scoliosis, crumpled ears and pectus deformities but excluding
the ocular and cardiovascular complications that characterize MFS. These two similar syndromes
result from mutations in two genes belonging to the ﬁbrillin family, FBN1 and FBN2, respectively.
We successfully identiﬁed a novel FBN2mutation (C1406R) in a Chinese family with CCA for over ﬁve
generations. This mutation was detected in the patients of this family but not in the seven unaf-
fected family members or 100 normal individuals. SIFT and PolyPhen analyses suggested that the
mutation was pathogenic. We identiﬁed a missense mutation in the calcium binding-epidermal
growth factor (cbEGF)-like domain. Our study extends the mutation spectrum of CCA and conﬁrms
a relationship between mutations in the FBN2 gene and the clinical ﬁndings of CCA.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Congenital contractural arachnodactyly (CCA) is a rare, autoso-
mal dominant connective tissue disorder characterized by contrac-
tures, arachnodactyly, dolichostenomelia, scoliosis, crumpled ears
and pectus deformities [1,2]. It is caused by mutations in the gene
encoding ﬁbrillin-2 (FBN2) on chromosome 5 [1,2]. CCA shares
overlapping features with Marfan syndrome (MFS), which is
caused by a mutation in the gene encoding ﬁbrillin-1 (FBN1) on
15q15-21.3 [1,2]. These genes encode large, cysteine-rich extra-
cellular matrix glycoproteins, ﬁbrillin-2 and ﬁbrillin-1, which are
major components of microﬁbrils. FBN2 is the only gene known
to be associated with CCA. This gene is >28 kb, contains 65 exons,
and encodes 2912 amino acids, comprising a multidomain protein
with ﬁve distinct structural regions. The largest of these structural
regions contains 41 calcium binding-epidermal growth factor
(cbEGF)-like domains. All of the identiﬁed mutations in FBN2 are
clustered within a deﬁned region similar to that in which severe
MFS mutations cluster in FBN1, speciﬁcally between exons 22
and 36 [3].
In many cases, CCA is caused by mutations in the ﬁbrillin2 gene
(FBN2), in which 48 mutations have been reported to date,including 31 missense and nonsense mutations, most of which
are located in the middle region of the FBN2 gene, from exon 22
to 36 [4–14].
In this study, we identiﬁed and characterized a Chinese family
with ﬁve generations of CCA. One novel mutation (c.4216T>C,
p.C1406A) in the FBN2 gene was identiﬁed in this family. The pres-
ence of the disease-causing mutation is consistent with the clinical
diagnosis of CCA, providing information for the genetic counseling
of other family members.
2. Materials and methods
2.1. DNA extraction and sequencing
Blood samples were obtained with informed consent from the
family members and from 100 normal individuals. Genomic DNA
was extracted from the blood samples using a DNA Isolation Kit
for Mammalian Blood (Tiangen Biotech, China). Primer sets were
used to amplify 65 exons (exon 1–65) of the FBN2 gene
(NM_001999) for sequencing. The sequences of the forward and
reverse primers of exon 32 were 50 TACTGGAAAGTGGCTGAC 30
and 50 CAAGGCATACTGTTGAAAT 30, respectively. The PCR condi-
tions for the DNA ampliﬁcation were as follows: denaturing at
95 C for 5 min; 30 cycles of denaturing at 95 C for 30 s, annealing
at 58 C for 30 s, and extension at 72 C for 30 s; and a ﬁnal step for
Fig. 1. Pedigree of the family that took part in this study. The patients with
congenital contractural arachnodactyly are depicted by darkened symbols. The
arrow indicates the proband.
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with the restriction enzyme MunI. The digested products were
separated and analyzed by 8% polyacrylamide gel electrophoresis
and silver staining.
2.2. Mutation analysis
To evaluate the mutation, several effective software programs
were used. A search was performed for human FBN2 homologs
using BLAST on the NCBI web site (http://www.ncbi.nlm.nih.gov).
The identiﬁed proteins were aligned using ClustalW [15], and a
phylogenetic tree was reconstructed with MEGA4 [16] with the
neighbor-joining method. The effect of the amino acid substitution
on the protein function was evaluated with SIFT [17,18] and
PolyPhen.
2.3. Ethics statement
This study was approved by the ethics committee of the Key
Laboratory of Reproductive Health of Liaoning Province, and
informed consent was obtained from all of the participants.Fig. 2. Phenotype of the family. (A) The proband, hands. (B) The proband, feet. (C) Patient
Patient III-6, hands. (H) Patient III-10, feet.3. Results and discussion
3.1. Clinical features of patients
We typed the CCA of this family, also known as Distal arthro-
gryposis type 9, for which ten affected individuals over ﬁve genera-
tions were evaluated (Fig. 1). All affected members of this family
presented with slender, contractural clubbed ﬁngers and toes
(Fig. 2A–H), and no neurological or cardiovascular abnormalities
were noted. Intrafamilial variation in phenotypic expression was
modest. The proband (Patient IV4) was a 36-year-old woman with
features typical of CCA. She was tall (163 cm) and thin (56 kg; body
mass index = 21.1) with contractural ﬁngers (Fig. 2A) and slender
toes (Fig. 2B), scoliosis, crumpled ears, 300 of myopia and exoph-
thalmos. Patient IV7 was 25 years old. He was tall (190 cm) and
thin, with contractural ﬁngers (Fig. 2C) and toes (Fig. 2D), scoliosis,
a pinched mouth, ptosis and prominent surface moles on the face.
Patient III4 was tall (178 cm) and thin (65 kg), with contractural
ﬁngers (Fig. 2E), abnormal ears, scoliosis, and ptosis. Patient IV8
was 28 years old. He was tall (183 cm) and had contractural ﬁngers
(Fig. 2F), a pinched mouth, ptosis and prominent surface moles on
the face. He had undergone surgery to correct his ﬁngers at the age
of 3. Patient III6 was tall (187 cm) and presented with contractural
ﬁngers (Fig. 2G), abnormal ears, scoliosis, and ptosis. Patient IV10
was 42 years old. She was tall (175 cm) presented with contrac-
tural toes (Fig. 2H), abnormal ears and scoliosis.
3.2. Identiﬁcation of a novel mutation in the FBN2 gene
The sequencing of 65 exons of FBN2 for mutation screening
revealed the presence of a heterozygous T? C transversion in
the patients at nucleotide position 4216 in exon 32, resulting in a
cysteine-to-arginine substitution at amino acid residue 1406
(C1406R) (Fig. 3). This mutation was identiﬁed in all affected
individuals in the family but not in any of the unaffected family
members, ﬁve unrelated spouses from other families, or 100 con-
trols. Using the SIFT program, which incorporates sequence homol-
ogy, the normalized probability of the substitution of C1406 to R
was calculated to be 0.00, which was less than the threshold of
0.05. Thus, this mutation was predicted to be deleterious. The
PolyPhen program predicted that this mutation was likely to be
damaging, with a score of 0.997. Eleven proteins in the FBN2 sub-
family were found by a BLAST search that formed a cluster in the
phylogenetic tree (Fig. 4). The C1406R mutation occurred in theIV-7, hands. (D) Patient IV-7, feet. (E) Patient III-4, hands. (F) Patient IV-8, hands. (G)
Fig. 3. DNA sequencing results for exon 32 of the FBN2 gene. The arrow indicates a heterozygous T? C transversion at 4216 nt of the cDNA (TGT? CGT, Cys1406Arg).
Fig. 4. The phylogenetic tree of FBN2. The bootstrap values are presented on the
branches.
W. Liu et al. / FEBS Open Bio 5 (2015) 163–166 16522nd cbEGF domain of the FBN2 gene. The alignment of cbEGF22–
23 revealed the presence of invariant cysteines in the cbEGF
domain that are conserved in a wide range of organisms, ranging
from humans to zebraﬁsh (Fig. 5).
3.3. Comparison of DA classiﬁcations with the CCA of this family
Distal arthrogryposis (DA) is an inherited limb malformation
disorder characterized by congenital contractures of two or more
body areas without primary neurological and/or muscular disease.
CCA is a unique type of distal arthrogryposis that shares overlap-
ping features with Marfan syndrome and distal arthrogryposis type
1 (DA1), but it is more severe than DA1 and less severe thanMarfan
syndrome. DA comprises a group of disorders that mainly involve
the distal parts of the limbs, characterized by congenital contrac-
tures of two or more different body areas. Ten different forms of
DA (DA1–DA10) have been reported to be autosomal dominant dis-
orders, and only DA5 shows an autosomal recessive inheritance
pattern. In contrast with the majority of families with CCA, in the
family evaluated in this study, two affected members presented
with prominent surface moles on face, extreme ptosis and scoliosisFig. 5. The alignment of ﬁbrillin cbEGF22–23 of different species. The conservsymptoms were common, and rare instances of myopia and exoph-
thalmos were noted.
Congenital contractural arachnodactyly is an autosomal domi-
nant disorder characterized by dolichostenomelia, contractures,
scoliosis, arachnodactyly, crumpled ears and pectus deformities.
It is caused by a mutation in the gene encoding ﬁbrillin-2 (FBN2)
on chromosome 5q23-q21 [1]. It shares overlapping features with
Marfan syndrome (MFS), which is caused by a mutation in the gene
encoding ﬁbrillin-1 (FBN1). CCA patients have crumpled ears and
congenital contractures and do not typically have the ocular or
life-threatening cardiovascular complications observed in MFS [2].
3.4. Prediction of protein functions for the substitutions
Here, we reported a novel mutation involving a T-to-C transi-
tion at position 4216 (c.4216T>C) in exon 32 of the FBN2 gene,
resulting in a Cys 1406 to Arg change (p.Cys1406Arg). All of the
patients in this family were conﬁrmed to have this mutation.
Because this mutation has not been previously reported, we
selected four software programs to evaluate its pathogenicity and
severity. All of the results indicated that this mutation is likely dis-
ease-causing because it is located within the region shared by most
reported CCA mutations and changes a conserved cysteine to an
arginine (C1408R), which is predicted to disrupt microﬁbril
structure.
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